Skip to main content

Adtalem Global Education Inc.

For the period ended Sep 30, 2025. Filed Oct 30, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Oct 30, 2025

CVSA$116.50+2.2%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Cash Flows

(in thousands)

​​​​​​​
​ · ​ · Three Months Ended
​ · ​ · September 30,
​ · ​ · 2025 · ​ · 2024
Operating activities:​​​​​​
Net income​$61,832​$46,165
(Income) loss from discontinued operations​(770)​80
Income from continuing operations​​61,062​​46,245
Adjustments to reconcile net income to net cash provided by operating activities:​​​​
Stock-based compensation​8,293​9,451
Amortization of operating lease assets​​7,216​​6,948
Depreciation​10,296​9,803
Amortization of acquired intangible assets​2,805​2,805
Amortization and write-off of debt discount and issuance costs​​1,145​​1,113
Provision for bad debts​​14,883​​13,720
Deferred income taxes​54,413​16,456
Loss on disposals and impairments of property and equipment​2​107
Gain on investments​​(680)​​(613)
Changes in assets and liabilities:​​​​
Accounts and financing receivables​(62,690)​(56,803)
Prepaid expenses and other current assets​(29,841)​(7,389)
Cloud computing implementation assets​(4,812)​(7,888)
Accounts payable​1,378​(8,508)
Accrued payroll and benefits​​(24,359)​​(21,501)
Accrued liabilities​(12,287)​(8,467)
Deferred revenue​109,082​106,156
Operating lease liabilities​​(4,317)​​(7,232)
Other assets and liabilities​(960)​(4,836)
Net cash provided by operating activities-continuing operations​130,629​89,567
Net cash used in operating activities-discontinued operations​(80)​(251)
Net cash provided by operating activities​130,549​89,316
Investing activities:​​​​​
Capital expenditures​(16,023)​(10,414)
Proceeds from sales of marketable securities​100​2,187
Purchases of marketable securities​(100)​(1,308)
Net cash used in investing activities​(16,023)​(9,535)
Financing activities:​​​​​
Proceeds from exercise of stock options​131​9,498
Employee taxes paid on withholding shares​(39,119)​(10,717)
Proceeds from stock issued under Colleague Stock Purchase Plan​411​298
Repurchases of common stock for treasury​(7,595)​(33,190)
Proceeds from issuance of long-term debt​—​9,873
Repayments of long-term debt​—​(9,873)
Payment of debt issuance costs​(3,333)​—
Net cash used in financing activities​(49,505)​(34,111)
Net increase in cash, cash equivalents and restricted cash​65,021​45,670
Cash, cash equivalents and restricted cash at beginning of period​201,164​221,202
Cash, cash equivalents and restricted cash at end of period​$266,185​$266,872
Non-cash investing and financing activities:​​​​​​
Accrued capital expenditures​$4,727​$4,193
Accrued liability for repurchases of common stock​$—​$800
Accrued excise tax on share repurchases​$1,630​$3,259
Accrued debt issuance costs​$437​$—
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.